减重手术对糖尿病肾病的长期影响
该回顾性研究纳入2005至2014年在学术中心接受减重手术的101例术前合并糖尿病且伴白蛋白尿(uACR>30 mg/g)的患者,评估减重手术对白蛋白尿的长期影响。中位随访61个月后,77%的患者白蛋白尿改善、51%缓解,提示减重手术对肥胖合并2型糖尿病患者的白蛋白尿有显著正向作用。
要点
- 减重手术可长期改善糖尿病患者的白蛋白尿,本组改善率77%、缓解率51%。
- 术后末次随访73%患者血糖控制良好(HbA1c<7%),27%达到糖尿病缓解标准。
- 术式以Roux-en-Y胃旁路术为主(74%),其余为袖状胃切除术(26%)。
核心结论
- 减重手术对肥胖合并2型糖尿病患者的白蛋白尿有显著正向影响,短期与长期改善率接近80%。
研究设计与样本
- 回顾性研究,纳入2005至2014年在学术中心接受减重手术的101例术前合并糖尿病且伴白蛋白尿的患者。
- 白蛋白尿定义为尿白蛋白与肌酐比值(uACR)>30 mg/g。
- 术式包括Roux-en-Y胃旁路术75例(74%)与袖状胃切除术26例(26%),平均随访61(±29)个月。
主要发现
- 术前平均BMI为43.1(±7.6)kg/m2,平均HbA1c为8.4(±1.8)%,中位uACR为80.0(45.0-231.0)mg/g。
- 末次随访平均BMI为33.8(±8.3)kg/m2,平均HbA1c为6.7(±1.0)%,中位uACR为30(IQR 7-94)mg/g。
- 末次随访73%血糖控制良好(HbA1c<7%),27%达到糖尿病缓解标准。
- 长期随访中白蛋白尿改善者占77%,缓解者占51%。
关键数值与推荐
- 白蛋白尿定义:uACR>30 mg/g。
- 血糖控制良好定义:HbA1c<7%,末次随访达标率73%。
- 糖尿病缓解标准:末次随访27%患者达到。
临床怎么用
- 对肥胖合并2型糖尿病且伴白蛋白尿的患者,减重手术可作为改善肾脏 end-organ 并发症的长期策略之一。
- 术后应长期监测uACR与HbA1c,以评估白蛋白尿改善与血糖控制情况。
局限性
- 为单中心回顾性研究,样本量101例。
- 未设非手术对照组,难以排除其他因素对白蛋白尿变化的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bariatric surgery has been shown to improve and resolve diabetes. However, limited literature about its impact on end-organ complications of diabetes is available. The aim of this study was to examine the long-term effect of bariatric surgery on albuminuria. METHODS: We studied 101 patients with pre-operative diabetes and albuminuria [defined as urine albumin:creatinine ratio (uACR) > 30 mg/g] who underwent bariatric surgery at an academic center from 2005 to 2014. RESULTS: Fifty-seven patients (56%) were female with a mean age of 53 (± 11) years. The mean pre-operative BMI and glycated hemoglobin (HbA1c) were 43.1 (± 7.6) kg/m2 and 8.4 (± 1.8)%, respectively. The median pre-operative uACR was 80.0 (45.0-231.0) mg/g. Bariatric procedures included Roux-en-Y gastric bypass (n = 75, 74%) and sleeve gastrectomy (n = 26, 26%). The mean follow-up period was 61 (± 29) months. At last follow-up, the mean BMI was 33.8 (± 8.3) kg/m2. The overall glycemic control improved after bariatric surgery. At last follow-up, 73% had good glycemic control (HbA1c < 7%) and 27% met diabetes remission criteria. The mean HbA1c at last follow-up was 6.7 (± 1.0)% and the median uACR was 30 (IQR 7-94) mg/g. Albuminuria improved in 77% and resolved in 51% of patients at long-term. CONCLUSIONS: Bariatric surgery has a significantly positive impact on albuminuria in patients with obesity and type 2 diabetes. Our data showed almost an 80% improvement in albuminuria at the short- and long-term period after bariatric surgery.
引用
- Young L, Nor Hanipah Z, Brethauer SA, et al. Long-term impact of bariatric surgery in diabetic nephropathy. Surg Endosc. 2018. PMID: 30251143. doi:10.1007/s00464-018-6458-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。